Functional significance of erythropoietin receptor on tumor cells

World Journal of Gastroenterology

Volumn 12, Issue 46, 2006, Pages 7460-7462

  Udupa, Kodetthoor B ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Cell signalling; Erythroid cell; Erythropoietin; Proliferation; Receptor; Tumor cell

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN ANTIBODY; ERYTHROPOIETIN RECEPTOR; PHENYLHYDRAZINE; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER PATIENT; CELL PROLIFERATION; CELL SURVIVAL; CHORIOCARCINOMA; DRUG ACTIVITY; ERYTHROID CELL; ERYTHROPOIESIS; GLIOBLASTOMA; GLIOMA CELL; HEAD AND NECK CARCINOMA; HEMATOCRIT; HUMAN; KIDNEY CARCINOMA; LIVER TUMOR; LUNG SMALL CELL CANCER; NEUROBLASTOMA; OVARY CARCINOMA; PANCREAS CANCER; PROSTATE CANCER; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; STOMACH CANCER; STOMACH CARCINOMA; TUMOR CELL; TUMOR GROWTH; UTERINE CERVIX CANCER;

EID: 33845896785     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i46.7460     Document Type: Article

References (20)

1. Zanjani ED, Ascensao JL. Erythropoietin. Transfusion 1989; 29: 46-57
2. Broudy VC, Lin N, Brice M, Nakamoto B, Papayannopoulou T. Erythropoietin receptor characteristics on primary human erythroid cells. Blood 1991; 77: 2583-2590
3. Sawada K, Krantz SB, Dai CH, Koury ST, Horn ST, Glick AD, Civin CI. Purification of human blood burst-forming units-erythroid and demonstration of the evolution of erythropoietin receptors. J Cell Physiol 1990; 142: 219-230
4. Lappin T. The cellular biology of erythropoietin receptors. The Oncologist 2003; 8 Suppl 1: 15-18
5. Goldwasser E, Kung CK, Eliason J. On the mechanism of erythropoietin-induced differentiation. 13. The role of sialic acid in erythropoietin action. J Biol Chem 1974; 249: 4202-4206
6. Eckardt KU, Bauer C. Erythropoietin in health and disease. Euro J Clin Invest 1989: 19: 117-127
7. Masuda S, Okano M, Yamagishi K, Nagao M, Ueda M, Sasaki R. A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J Biol Chem 1994; 269: 19488-19493
8. Acs G, Acs P, Beckwith SM, Pitts RL, Clements E, Wong K, Verma A. Erythropoietin and erythropoietin receptor expression in human cancer. Cancer Res 2001; 61: 3561-3565
9. Westenfelder C, Baranowski RL. Erythropoietin stimulates proliferation of human renal carcinoma cells. Kidney Int 2000; 58: 647-657
10. Acs G, Zhang PJ, Rebbeck TR, Acs P, Verma A. Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma. Cancer 2002; 95: 969-981
11. McBroom JW, Acs G, Rose GS, Krivak TC, Mohyeldin A, Verma A. Erythropoietin receptor function and expression in epithelial ovarian carcinoma. Gynecol Oncol 2005; 99: 571-577
12. Belenkov AI, Shenouda G, Rizhevskaya E, Cournoyer D, Belzile JP, Souhami L, Devic S, Chow TY. Erythropoietin induces cancer cell resistance to ionizing radiation and to cisplatin. Mol Cancer Ther 2004; 3: 1525-1532
13. Arcasoy MO, Amin K, Karayal AF, Chou SC, Raleigh JA, Varia MA, Haroon ZA. Functional significance of erythropoietin receptor expression in breast cancer. Lab Invest 2002; 82: 911-918
14. Wollman Y, Westphal G, Blum M, Simantov R, Blumberg S, Peer G, Chernihovsky T, Friedrich E, Iaina A. The effect of human recombinant erythropoietin on the growth of a human neuroblastoma cell line. Life Sci 1996; 59: 315-322
15. Feldman L, Wang Y, Rhim JS, Bhattacharya N, Loda M, Sytkowski AJ. Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells. Prostate 2006; 66: 135-145
16. Yasuda Y, Fujita Y, Matsuo T, Koinuma S, Hara S, Tazaki A, Onozaki M, Hashimoto M, Musha T, Ogawa K, Fujita H, Nakamura Y, Shiozaki H, Utsumi H. Erythropoietin regulates tumour growth of human malignancies. Carcinogenesis 2003; 24: 1021-1029
17. Nakamatsu K, Nishimura Y, Suzuki M, Kanamori S, Maenishi O, Yasuda Y. Erythropoietin/erythropoietin-receptor system as an angiogenic factor in chemically induced murine hepatic tumors. Int J Clin Oncol 2004; 9: 184-188
18. Lai SY, Childs EE, Xi S, Coppelli FM, Gooding WE, Wells A, Ferris RL, Grandis JR. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma. Oncogene 2005; 24: 4442-4449
19. Lester RD, Jo M, Campana WM, Gonias SL. Erythropoietin promotes MCF-7 breast cancer cell migration by an ERK/mitogen-activated protein kinase-dependent pathway and is primarily responsible for the increase in migration observed in hypoxia. J Biol Chem 2005; 280: 39273-39277
20. Elliott S, Busse L, Bass MB, Lu H, Sarosi I, Sinclair AM, Spahr C, Um M, Van G, Begley CG. Anti-Epo receptor antibodies do not predict Epo receptor expression. Blood 2006; 107: 1892-1895